Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Anti-HBsAg Reference Antibody (OST 577)

Catalog #:   DVV03006 Specific References (50) DATASHEET
Host species: Human
Isotype: IgG1-lambda
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DVV03006

Expression system

Mammalian Cells

Species reactivity

Hepatitis B virus genotype A2 subtype adw (isolate Japan/Nishioka/1983) (HBV-A)

Host species

Human

Isotype

IgG1-lambda

Clonality

Monoclonal

Target

Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P03142

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

OST 577, OST577, OST-577

Clone ID

OST 577

Data Image
References

Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection., PMID:40486136

Hepatitis B and C Screening and Linkage to Care in Migrants From Endemic Countries in Barcelona Through a Community Action., PMID:40351294

Impact of the Hepatitis B Immunization Strategy Adopted in Italy from 1991: The Results of a Seroprevalence Study on the Adult Population of Florence, Italy., PMID:40333169

Longstanding, undiagnosed, highly replicative hepatitis B virus reactivation in the presence of high levels of anti-HBs antibodies., PMID:40319465

Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response., PMID:40276479

A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D., PMID:40214253

Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B model., PMID:40143948

Hepatitis Delta and Liver Disease Among People Living With Hepatitis B With or Without HIV Co-Infection in Senegal., PMID:39967446

Screening for HBV, HCV, TP and HIV in pregnant women from various ethnic groups in Yili, Xinjiang, China., PMID:39923940

Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection., PMID:39903324

Prevalence and molecular characterization of hepatitis delta virus infection among hepatitis B virus surface antigen positive students and pregnant women in N'djamena, Chad., PMID:39895833

Community prevalence of blood-borne viruses (hepatitis B and HIV) in Ireland., PMID:39847252

A novel method for recombinant mammalian-expressed S-HBsAg virus-like particle production for assembly status analysis and improved anti-HBs serology., PMID:39660966

A three antigen hepatitis B vaccine induces T cells to Pres1 and Pres2 which correlate with anti HBs antibody titers: An investigation into the immunological mechanisms contributing to high anti-HBs titers., PMID:39536477

The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines., PMID:39460290

Safety of Hepatitis B Virus Screening in Blood Donors from the Hospital Foundation of Hematology and Hemotherapy of the State of Amazonas (HEMOAM) in the Brazilian Amazon., PMID:39459965

The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study., PMID:39205210

Assessing the diagnostic accuracy of serological tests for hepatitis delta virus diagnosis: a systematic review and meta-analysis., PMID:39122751

The diagnostic cascade for patients with hepatitis delta infection in France, 2018-2022: A cross-sectional study., PMID:39115174

Effect of hepatitis B vaccination on HBV-infection among school children in Yaounde; ten years after the introduction of HBV vaccine into routine Immunization Program in Cameroon., PMID:39036018

Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon., PMID:38900729

Low Prevalence of Anti-HBc Antibody and Lack of HBV DNA Among HBsAg-Negative Blood Donors in Iran: A Cross-sectional Study and Review of Literature., PMID:38855800

Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana., PMID:38784816

Evaluation of a fully automated high-throughput serology assay for detection of Hepatitis D virus antibodies., PMID:38781633

Decentralised same day test and treatment of hepatitis C levering existing peer support networks among men who inject drugs: feasibility and effectiveness., PMID:38769517

Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component., PMID:38425450

An Anatomically Complicated Living Donor Kidney Transplantation from Hepatitis B Surface Antigen-Positive Donor to Negative Recipient With Size Discrepancy., PMID:38342747

Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland., PMID:38328514

Protection level of anti-hepatitis B vaccine and immunoglobulin in a pediatric Cameroonian population., PMID:38204806

Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings., PMID:38093205

Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination., PMID:38074506

Successful results of early nucleos(t)ide analogue treatment for liver transplantation candidates with severe acute hepatitis B infection., PMID:37823433

Living-donor lobar lung transplantation from a hepatitis B surface antigen-positive donor to a negative recipient., PMID:37816581

Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors., PMID:37796091

Prevalence of hepatitis B and C viral co-infection and associated factors with HIV infection in children in South Kivu, Democratic Republic of the Congo., PMID:37580665

Novel anti‑hepatitis B virus flavonoids sakuranetin and velutin from Rhus retinorrhoea., PMID:37539729

World Hepatitis day 2021 -screening and vaccination against Hepatitis B virus in Accra, Ghana., PMID:37328849

A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape., PMID:37112819

Overall survival among patients who undergo resection does not differ significantly between T1a and T1b hepatocellular carcinoma based on the 8th American Joint Commission on Cancer., PMID:37103595

A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa., PMID:36870990

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector., PMID:36851527

Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination., PMID:36816726

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection., PMID:36748051

Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance., PMID:36714793

Seroepidemiology of HBV, HCV, HIV, HTLV, and CMV in Pregnant Women Referring to Sari Birth Cohort., PMID:36660762

Hepatitis B burden and population immunity in a high endemicity city - a geographically random household epidemiology study for evaluating achievability of elimination., PMID:36628568

Evaluation of factors associated the expression of anti-HBs in children in Hunan Province, China., PMID:36471266

Diagnostic performances of Exacto® Triplex rapid test for diagnosis of HIV/HCV/HBsAg: a multicenter, cross-sectional, field study in the Central African Republic., PMID:36451724

Insights on 21 Years of HBV Surveillance in Blood Donors in France., PMID:36423116

Automated and combined HIV, HBV, HCV, and syphilis testing among illegal gold miners in French Guiana using a standardized dried blood device., PMID:36395882

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Anti-HBsAg Reference Antibody (OST 577) [DVV03006]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only